Figure (Dal03 0001 01)
Chemical structure of dalbavancin hydrochloride, the active ingredient in Dalbavancin injection powder for solution.*
Dalbavancin Injection, Powder, For Solution
Product Images NDC 81298-2390
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dalbavancin (NDC 81298-2390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Long Grove Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Dal03 0001 02)
Dalbavancin For Injection 500 mg per vial packaging label for sterile single-dose vial, powder for solution for intravenous infusion. The label includes storage instructions, reconstitution and dilution details, and notes that it is manufactured by Long Grove Pharmaceuticals, LLC. The label features the Long Grove logo and a barcode.*
Figure (Dal03 0001 03)
Label for Dalbavancin 500 mg injection powder for solution, intended for intravenous use. The label states it is a sterile single-dose vial. It is manufactured by Long Grove Pharmaceuticals, LLC, Rosemont, IL, and made in India. The label includes storage instructions, reconstitution and dilution details, and barcodes, with a lot and expiration date area blank.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
